Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Immune Enhancement for Immunological Non-responders to ART (IMMUNE)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
David M. Guidot, MD, Emory University
ClinicalTrials.gov Identifier:
NCT01806870
First received: March 6, 2013
Last updated: November 7, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: June 2017
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)